Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ImmunoTools is a German biotechnology company that specializes in the development, production, and distribution of high-quality reagents for immunology and cell biology research. The company's extensive product portfolio includes monoclonal antibodies, recombinant cytokines, ELISA kits, and MHC-multimers, which are essential for applications such as flow cytometry and functional assays. ImmunoTools is particularly recognized for its commitment to providing cost-effective solutions to the global scientific community, often offering products at significantly lower prices than larger competitors. Their manufacturing processes focus on high purity and biological activity, ensuring reliable results for academic and industrial researchers. Based in Friesoythe, Germany, the company serves a diverse range of therapeutic areas, including oncology, hematology, and infectious diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ImmunoTools.